Physician profile
Jared Michael Davis
NPI 1528384195
$89,336.42
in general payments reported to CMS, 2019-2025
33 companies · $4,402 in 2025
The $4,402 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,582 · 2020: $3,847 · 2021: $24K · 2022: $32K · 2023: $19K · 2024: $2,991 · 2025: $4,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $4,815 · Food and Beverage: $3,785 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,927.50 |
| Travel and Lodging | $4,814.78 |
| Food and Beverage | $3,785.23 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $590.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $81,285.99 | 2020-2025 | Integra, Omnigraft, Durasorb Monofilament Mesh |
| Mentor Worldwide LLC | $1,020.84 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,013.14 | 2019 | |
| Stryker Corporation | $811.25 | 2019-2025 | Na, Smartlock, Vsp System, Vsp Cranial |
| Depuy Synthes Sales INC. | $613.33 | 2019-2024 | Na |
| Kls-Martin L.P. | $609.50 | 2019-2024 | |
| Kerecis Limited | $602.35 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Axogen | $581.42 | 2019-2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Tela Bio, INC. | $456.18 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $412.90 | 2024-2025 | Phasix Mesh, Arista |
| Sientra, INC. | $362.32 | 2021-2022 | |
| Revance Therapeutics, INC. | $255.89 | 2025 | Daxxify |
| Allergan, INC. | $208.59 | 2021-2022 | |
| Baxter Healthcare | $193.94 | 2022 | |
| Sonex Health, INC. | $140.80 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $125.68 | 2025 | |
| Dilon Technologies, INC. | $118.23 | 2025 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $98.10 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $68.25 | 2024 | |
| Acera Surgical, INC. | $52.99 | 2019 | |
| Access Pro Medical, LLC | $51.43 | 2022-2023 | Matriderm |
| Smith+Nephew, INC. | $37.94 | 2021 | |
| Zimmer Biomet Holdings, INC. | $36.80 | 2019 | |
| Sanara Medtech INC. | $31.36 | 2022-2023 | Celleraterx |
| Kci USA, INC. | $29.15 | 2019 | |
| Foundation Medicine, INC. | $18.29 | 2021 | |
| Solventum Corporation | $16.05 | 2024 | Prevena |
| Aroa Biosurgery Incorporated | $15.43 | 2019 | |
| Endo Pharmaceuticals INC. | $15.07 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.75 | 2023 | Enhertu |
| Tei Biosciences INC | $14.40 | 2019 | |
| Galderma Laboratories, L.P. | $14.20 | 2021 | |
| Medela LLC | $9.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.